BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26899297)

  • 21. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group.
    Hagiya H; Yamamoto N; Kawahara R; Akeda Y; Shanmugakani RK; Ueda A; Nishi I; Asada R; Yoshida H; Tomono K
    J Infect Chemother; 2018 Sep; 24(9):769-772. PubMed ID: 29656900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
    Netikul T; Kiratisin P
    PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
    Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2014 Mar; 58(5):697-703. PubMed ID: 24304707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alarming prevalence of community-acquired multidrug-resistant organisms colonization in children with cancer and implications for therapy: A prospective study.
    Thacker N; Pereira N; Banavali SD; Narula G; Vora T; Chinnaswamy G; Prasad M; Kelkar R; Biswas S; Arora B
    Indian J Cancer; 2014; 51(4):442-6. PubMed ID: 26842153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.
    Abboud CS; Monteiro J; Stryjewski ME; Zandonadi EC; Barbosa V; Dantas D; Sousa EE; Fonseca MJ; Jacobs DM; Pignatari AC; Kiffer C; Rao GG
    Int J Antimicrob Agents; 2016 May; 47(5):386-90. PubMed ID: 27155944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.
    Swaminathan M; Sharma S; Poliansky Blash S; Patel G; Banach DB; Phillips M; LaBombardi V; Anderson KF; Kitchel B; Srinivasan A; Calfee DP
    Infect Control Hosp Epidemiol; 2013 Aug; 34(8):809-17. PubMed ID: 23838221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study.
    Bart Y; Paul M; Eluk O; Geffen Y; Rabino G; Hussein K
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):936-41. PubMed ID: 25869912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbapenem-resistant Enterobacteriaceae and endoscopy: An evolving threat.
    O'Horo JC; Farrell A; Sohail MR; Safdar N
    Am J Infect Control; 2016 Sep; 44(9):1032-6. PubMed ID: 27179395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates.
    Tang HJ; Hsieh CF; Chang PC; Chen JJ; Lin YH; Lai CC; Chao CM; Chuang YC
    PLoS One; 2016; 11(3):e0151897. PubMed ID: 26999356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.
    Ciobotaro P; Flaks-Manov N; Oved M; Schattner A; Hoshen M; Ben-Yosef E; Balicer RD; Zimhony O
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):188-96. PubMed ID: 26750741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
    Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates.
    Singh N; Patel KM; Léger MM; Short B; Sprague BM; Kalu N; Campos JM
    Pediatr Infect Dis J; 2002 Nov; 21(11):1029-33. PubMed ID: 12442024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.
    Thaden JT; Lewis SS; Hazen KC; Huslage K; Fowler VG; Moehring RW; Chen LF; Jones CD; Moore ZS; Sexton DJ; Anderson DJ
    Infect Control Hosp Epidemiol; 2014 Aug; 35(8):978-83. PubMed ID: 25026612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.
    Reuben J; Donegan N; Wortmann G; DeBiasi R; Song X; Kumar P; McFadden M; Clagon S; Mirdamadi J; White D; Harris JE; Browne A; Hooker J; Yochelson M; Walker M; Little G; Jernigan G; Hansen K; Dockery B; Sinatro B; Blaylock M; Harmon K; Iyengar P; Wagner T; Nelson JA;
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):921-929. PubMed ID: 28615088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenem-resistant Enterobacteriaceae Infections in Children: An Italian Retrospective Multicenter Study.
    Montagnani C; Prato M; Scolfaro C; Colombo S; Esposito S; Tagliabue C; Lo Vecchio A; Bruzzese E; Loy A; Cursi L; Vuerich M; de Martino M; Galli L;
    Pediatr Infect Dis J; 2016 Aug; 35(8):862-8. PubMed ID: 27100130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.